P150 ORAL PROPHYLAXIS WITH BCX7353 REDUCES HAE ATTACK RATES AND IS WELL-TOLERATED: APEX-2 STUDY RESULTS

Autor: Zuraw, B., Lumry, W., Banerji, A., Aygoren-Pursun, E., Bernstein, J., Johnston, D., Christiansen, S., Riedl, M., Cicardi, M., Maurer, M., Cornpropst, M., Dobo, S., Iocca, H., Nagy, E., Murray, S., Collis, P., Sheridan, W.
Zdroj: In Annals of Allergy, Asthma & Immunology November 2019 123(5) Supplement:S27-S27
Databáze: ScienceDirect